Tomoya Yamada
9PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 19, 2026
Response to the Letter from Professor C. R. Wolf and colleagues concerning CRT, 55: 549-586, 2025: The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome-proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation.Tomoya Yamada, Samuel M Cohen, Brian G Lake
|Jun 27, 2025
The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation.Tomoya Yamada, Samuel M Cohen, Brian G Lake
|Jun 09, 2025
An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action.Kensuke Kawamoto, Yukako Shimotsuma, Keiko Maeda
|Aug 16, 2022
Response to Letter to the Editor from Drs. van Kesteren, Pronk, Heusinkveld, Luijten and Hakkert concerning Yamada et al. (2021): Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit. Rev. Toxicol. Vol. 51: 373-394.Tomoya Yamada, Samuel M Cohen, Brian G Lake
|Mar 11, 2022
Evaluation of the human hazard of the liver and lung tumors in mice treated with permethrin based on mode of action.Tomoya Yamada, Brian G Lake, Samuel M Cohen
|Aug 24, 2021
Club Cells Are the Primary Target for Permethrin-Induced Mouse Lung Tumor Formation.Keiko Ogata, Yang Liu, Ayako Ohara
Pageof 2
